Novartis Annual Report 2016-PDF Free Download

https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf

>>Novartis Annual Report 2016-PDF Free Download Pdf [Fast DOWNLOAD]<<


Related Books

Novartis Annual Report 2016 - Corporate Responsibility

Novartis Annual Report 2016 - Corporate Responsibility

tackling infectious diseases and are ill-equipped to address the needs of patients with chronic illnesses. This cannot be solved by one organization alone, so we partner with organizations that can contribute their skills and capabilities. Our distribution partners include MEDS and the Kenya Red Cross. We are also working with Management Sciences for Health to assess the supply chains in ...

Continue Reading...
Novartis Annual Report 2017

Novartis Annual Report 2017

more than 70 new molecules in areas of high unmet medical need such as cancer, respiratory disease and heart disease. Joerg Reinhardt. ... the World” list in 2017, and we moved to fourth in the 2017 Dow Jones Sustainability Index World, up from seventh in 2016. We continued to expand our efforts to eliminate malaria, for example by working with Medicines for Malaria Venture to initiate a ...

Continue Reading...
NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

In August 2015, Novartis signed a new Memorandum with WHO, extending the provision of multidrug therapy (MDT) free of charge to all leprosy patients worldwide until the end of 2020; the Company’s collaboration with WHO began in 2000, and was renewed twice, in 2005 and 2010. The year 2016 marked 30 years of Novartis Foundation’s commitment to support the leprosy-afflicted. I thank you for ...

Continue Reading...
Novartis Annual Report 2016

Novartis Annual Report 2016

In an effort to build Novartis into a company that can thrive no matter what the future holds, we made significant changes in 2016 to create a more sustainable company Last year we reshaped Novartis from a group of loosely affiliated divisions into an integrated company, consoli-dating several functions. We created a Global Drug

Continue Reading...
Novartis Annual Report 2016

Novartis Annual Report 2016

4 | Novartis Annual Report 2016 the Novartis Oncology business unit, with its unique customer base, now reports directly to me, given its growing importance. We also consolidated all of our eye care drugs into the Novartis Pharmaceuticals business unit, and focused Alcon solely on surgical and vision care.

Continue Reading...
Annual Report 2016 - Pensionskassen Novartis

Annual Report 2016 - Pensionskassen Novartis

8 | ANNUAL REPORT 2016 The Board of Trustees of the Novartis Pension Fund 1 is made up equally of 7 employer’s and 7 employees’ repre - sentatives. Organization Novartis Pension Fund 1 (as of December 31, 2016) Board of Trustees (Period of office from 1 January 2013 until 31 December 2016) Management Dr. Markus Moser, Managing Director

Continue Reading...
NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

NOVARTIS INDIA LIMITED annual report 2016 - 2017. 04 Dear Shareholder, Novartis continues with its long-term commitment to ensure access to medicines. The environment in which the pharmaceutical industry operates continues to see unprecedented change, particularly at the policy level. The National Health Policy 2017 proposes raising public health expenditure to 2.5% of the GDP in a time-bound ...

Continue Reading...
Novartis Annual Report 2015

Novartis Annual Report 2015

260 Key Dates 2016, Contact Information and Forward-Looking Statements CONTENTS. 2 | Novartis Annual Report 2015 Dear shareholder, In 2015, Novartis completed a portfolio transformation to focus on three leading divisions, strengthen our pharmaceuticals operation, and leverage our new services organization to improve productivity and profitability. We also achieved important milestones in ...

Continue Reading...
NoVarTIS INdIa LImITed aNNuaL reporT 2015-16

NoVarTIS INdIa LImITed aNNuaL reporT 2015-16

NoVartis iNdia LiMited 04 annual report 2015 - 2016 dear shareholder Novartis has a long-term commitment to ensure access to medicines. in an interconnected and shrinking world that has seen unprecedented levels of disruption in most industries, the pharmaceutical industry particularly lives in extraordinarily volatile times.

Continue Reading...
Novo Nordisk Annual Report 2019

Novo Nordisk Annual Report 2019

This Annual Report is Novo Nordisk’s full statutory Annual Report 2019. Please read further details in 'More information'. Contents Novo Nordisk Annual Report 2019. Letter from the Chair Making good progress Novo Nordisk made good progress during 2019. Our teams have delivered growth and crucial new product launches. This has established a good platform for the next decade and beyond as we ...

Continue Reading...
Stichting Access to Medicine Foundation Annual Report 2016

Stichting Access to Medicine Foundation Annual Report 2016

Stichting Access to Medicine Foundation - Annual Report 2016 Table of contents Executive Board Report 3 Summary of the Audited Financial Statements 2016 11 Balance sheet as at 31 December 2016 12 Statement of income and expenses for the year ended 31 December 2016 13 Notes to the Summary of the Audited Financial Statements 2016 14

Continue Reading...